Question 1

How many shares of NKTR does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 428,400 shares of NKTR (Nektar Therapeutics).

Question 2

What is UBS Group AG's NKTR position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's NKTR position is worth $29.9M.

Question 3

Is UBS Group AG buying or selling NKTR?

Accepted Answer

In 2026-Q2, UBS Group AG increased their NKTR position (+33.8% change in shares).

Question 4

When did UBS Group AG first buy NKTR?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in NKTR in 2025-Q2. They have held the position across 5 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	428,400	+33.8%	$29.9M	0.0%	$69.81	37
2026-Q1	Increased	320,172	+11.3%	$23M	0.0%	$68.11	32
2025-Q4	Increased	287,561	+216.6%	$12.2M	0.0%	$41.90	45
2025-Q3	Decreased	90,822	-54.9%	$5.2M	0.0%	$58.92	0
2025-Q2	New	201,371	-	$5.2M	0.0%	$25.76	37

NKTR5 quarters

NKTR
5 quarters